These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38950019)

  • 1. High prevalence of long-term olfactory disorders in healthcare workers after COVID-19: A case-control study.
    Frasnelli J; Tognetti A; Winter AL; Thunell E; Olsson MJ; Greilert N; Olofsson JK; Havervall S; Thålin C; Lundström JN
    PLoS One; 2024; 19(7):e0306290. PubMed ID: 38950019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss.
    Ohla K; Veldhuizen MG; Green T; Hannum ME; Bakke AJ; Moein ST; Tognetti A; Postma EM; Pellegrino R; Hwang DLD; Albayay J; Koyama S; Nolden AA; Thomas-Danguin T; Mucignat-Caretta C; Menger NS; Croijmans I; Ã-ztà Rk L; YanÄ K H; Pierron D; Pereda-Loth V; Nunez-Parra A; Martinez Pineda AM; Gillespie D; Farruggia MC; Cecchetto C; Fornazieri MA; Philpott C; Voznessenskaya V; Cooper KW; Rohlfs Dominguez P; Calcinoni O; de Groot J; Boesveldt S; Bhutani S; Weir EM; Exten C; Joseph PV; Parma V; Hayes JE; Niv MY
    Rhinology; 2022 Jun; 60(3):207-217. PubMed ID: 35398877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.
    D'Ascanio L; Pandolfini M; Cingolani C; Latini G; Gradoni P; Capalbo M; Frausini G; Maranzano M; Brenner MJ; Di Stadio A
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):82-86. PubMed ID: 32662745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-Related Quantitative and Qualitative Olfactory and Gustatory Dysfunction: Long-Term Prevalence and Recovery Rate.
    Boscolo-Rizzo P; Tofanelli M; Zanelli E; Gardenal N; Tirelli G
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):67-71. PubMed ID: 36063810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results.
    Jensen MM; Larsen KD; Homøe AS; Simonsen AL; Arndal E; Koch A; Samuelsen GB; Nielsen XC; Todsen T; Homøe P
    PLoS One; 2022; 17(10):e0275518. PubMed ID: 36191024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.
    Kusnik A; Weiss C; Neubauer M; Huber B; Gerigk M; Miethke T; Hunter N; Rotter N; Ludwig S; Schell A; Ebert MP; Teufel A
    BMC Infect Dis; 2021 Jun; 21(1):612. PubMed ID: 34174816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychophysical assessment of olfactory and gustatory function in post-mild COVID-19 patients: A matched case-control study with 2-year follow-up.
    Boscolo-Rizzo P; Hummel T; Invitto S; Spinato G; Tomasoni M; Emanuelli E; Tofanelli M; Cavicchia A; Grill V; Vaira LA; Lechien JR; Borsetto D; Polesel J; Dibattista M; Menini A; Hopkins C; Tirelli G
    Int Forum Allergy Rhinol; 2023 Oct; 13(10):1864-1875. PubMed ID: 36852674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Lasting Olfactory Dysfunction in Hospital Workers Due to COVID-19: Prevalence, Clinical Characteristics, and Most Affected Odorants.
    Delgado-Losada ML; Bouhaben J; Ruiz-Huerta C; Canto MV; Delgado-Lima AH
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory dysfunction in patients after recovering from COVID-19.
    Otte MS; Eckel HNC; Poluschkin L; Klussmann JP; Luers JC
    Acta Otolaryngol; 2020 Dec; 140(12):1032-1035. PubMed ID: 32852240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013876. PubMed ID: 34291813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence.
    Rebholz H; Pfaffeneder-Mantai F; Knoll W; Hassel AW; Frank W; Kleber C
    Am J Otolaryngol; 2021; 42(5):103014. PubMed ID: 33873048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study.
    Lechien JR; Vaira LA; Saussez S
    J Intern Med; 2023 Jan; 293(1):82-90. PubMed ID: 36000469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of olfactory dysfunction persistence after COVID-19: a prospective study.
    Bianco MR; Ralli M; Minni A; Greco A; de Vincentiis M; Allegra E
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1042-1048. PubMed ID: 35179771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating long-term smell or taste dysfunction in mildly symptomatic COVID-19 patients: a 3-year follow-up study.
    Boscolo-Rizzo P; Spinato G; Hopkins C; Marzolino R; Cavicchia A; Zucchini S; Borsetto D; Lechien JR; Vaira LA; Tirelli G
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5625-5630. PubMed ID: 37715807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory and taste dysfunctions caused by COVID-19: a nationwide study.
    Miwa T; Mori E; Sekine R; Kimura Y; Kobayashi M; Shiga H; Tsuzuki K; Suzuki M; Kondo K; Suzaki I; Inokuchi G; Aiba T; Chujo K; Yagi-Nakanishi S; Tsukatani T; Nakanishi H; Nishijo M; Iinuma Y; Yokoyama A
    Rhinology; 2023 Dec; 61(6):552-560. PubMed ID: 37690065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and clinical outcomes of olfactory and gustatory disorders in six months: Prospective study of 1031 COVID-19 patients.
    Teaima AA; Salem OM; Teama MAEM; Mansour OI; Taha MS; Badr FM; Khater SS; Abdou K; Mahmoud MS
    Am J Otolaryngol; 2022; 43(1):103259. PubMed ID: 34626912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19.
    Boscolo-Rizzo P; Menegaldo A; Fabbris C; Spinato G; Borsetto D; Vaira LA; Calvanese L; Pettorelli A; Sonego M; Frezza D; Bertolin A; Cestaro W; Rigoli R; D'Alessandro A; Tirelli G; Da Mosto MC; Menini A; Polesel J; Hopkins C
    Chem Senses; 2021 Jan; 46():. PubMed ID: 33575808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.